IR-MED Inc (OTCMKTS:IRME) Stock In Focus Following Key Update
IR-MED Inc (OTCMKTS:IRME) is involved in the development of an artificial intelligence-powered spectrographic analysis technology platform that is meant to provide assistance for a number of significant healthcare needs.
IR-Med’s PressureSafe Noninvasive Wound Care Device to be Demonstrated at Northwell Health’s 10th Annual Shining the Light on Wound Care Symposium
Last Friday the company announced that its PressureSafe wound care device would be exhibited and live demonstrations would also be held at Northwell Health’s 10th Annual Shining the Light on Wound Care Symposium. The event took place on May 19 at the TWA Hotel located at the JFK International Airport in New York. PressureSafe is a product that has shown considerable accuracy in the identification of Stage 1 injuries in a non-invasive manner in feasibility studies.
The company noted in its press release yesterday that at the event the product was going to be exhibited to as many as 250 wound care specialists. The device deploys a penetrating infrared light for the purpose of going beneath the surface of the skin and sensing biomarkers as well as structural changes in the tissue layers. The data gleamed from this is then processed by artificial intelligence software so as to provide clinical analysis about the injuries. The device is also recalibrated as per the skin of each patient.